Research ArticleClinical Studies

The Long-term Outcomes of Borderline Resectable T3 in Locally Advanced Esophageal Squamous Cell Carcinoma Treated With Neoadjuvant Triplet Chemotherapy

JUNYA KITADANI, KEIJI HAYATA, TARO GODA, SHINTA TOMINAGA, NAOKI FUKUDA, TOMOKI NAKAI, SHOTARO NAGANO and MANABU KAWAI
Anticancer Research May 2025, 45 (5) 2225-2235; DOI: https://doi.org/10.21873/anticanres.17596

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

patientACCESS

patientACCESS - Patients desiring access to articles
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
The Long-term Outcomes of Borderline Resectable T3 in Locally Advanced Esophageal Squamous Cell Carcinoma Treated With Neoadjuvant Triplet Chemotherapy
JUNYA KITADANI, KEIJI HAYATA, TARO GODA, SHINTA TOMINAGA, NAOKI FUKUDA, TOMOKI NAKAI, SHOTARO NAGANO, MANABU KAWAI
Anticancer Research May 2025, 45 (5) 2225-2235; DOI: 10.21873/anticanres.17596
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords